Recent Finacing
Recent Raise
Curesponse provides a clinical platform combining rapid genomic sequencing with a 3D functional tumor assay that preserves microenvironment interactions to empirically predict patient-specific cancer treatment responses.
Focus Areas
Total Raised
Funding round
See the team members at CuResponse.
